Group 1 - China Shipbuilding plans to absorb and merge China Shipbuilding Industry Corporation through a share exchange, with trading suspension starting from August 13, 2025 [1] - China Shipbuilding was established in May 1998, focusing on shipbuilding (military and civilian), ship repair, marine engineering, and electromechanical equipment [1] Group 2 - SanChao New Materials intends to raise 250 million yuan through a private placement to Wuxi Boda He Yi Technology Co., with a share price of 20.04 yuan [2] - SanChao New Materials is undergoing a change in control, with Boda He Yi acquiring a total of 18.99 million shares, making it the controlling shareholder [2][3] Group 3 - Zhenyou Technology's actual controller plans to transfer 5% of the company's shares to Shenzhen Century Zhiyuan Private Equity Fund Management Co., at a price of 22.13 yuan per share, totaling 213 million yuan [4] - Zhenyou Technology was established in April 2005, focusing on the design, research, sales, and service of communication system equipment [4] Group 4 - Zhizheng Co. is set to undergo a major asset restructuring, with the Shanghai Stock Exchange scheduled to review the transaction on August 11, 2025 [5] - Zhizheng Co. was established in December 2004, specializing in high polymer materials for cables and semiconductor equipment [5] Group 5 - Shaoneng Co. reported a net profit of 95.90 million yuan for the first half of 2025, a year-on-year decrease of 42.43%, despite a revenue increase of 6.95% to 2.335 billion yuan [6] - Shaoneng Co. was established in June 1993, focusing on energy (electricity, heating, steam), ecological plant fiber products, and precision manufacturing [6] Group 6 - Lide New Energy reported a net profit of 8.95 million yuan for the first half of 2025, down 90.17%, with revenue of 496 million yuan, a decrease of 6.02% [7] - Lide New Energy was established in August 2013, focusing on investment, development, construction, and operation of wind and solar power projects [7] Group 7 - Zhongdian Environmental Protection achieved a net profit of 53.94 million yuan in the first half of 2025, a year-on-year increase of 2.87%, despite a revenue decline of 10.70% to 315 million yuan [8] - Zhongdian Environmental Protection was established in January 2001, specializing in the research, manufacturing, sales, and service of ecological environmental governance equipment [8] Group 8 - Qiaoyuan Co. has decided to terminate its intention to acquire the controlling stake in Deyang Hongchen Chemical Co. due to a lack of consensus among parties [10] - Qiaoyuan Co. was established in November 2001, focusing on the cleaning, collection, transportation, and treatment of municipal solid waste [10] Group 9 - ST Changfang plans to publicly transfer part of its assets, including the Ping Shan Changfang Industrial Park, with a starting price of 374 million yuan [12] - ST Changfang was established in May 2005, focusing on the research, design, production, and sales of LED off-grid lighting and other electronic products [12] Group 10 - He Xin Instruments reported a net loss of 17.46 million yuan for the first half of 2025, with revenue of 52.82 million yuan, down 48.88% [13] - He Xin Instruments was established in June 2004, focusing on the research, production, and sales of mass spectrometers and related technologies [13] Group 11 - Fengli Intelligent plans to raise no more than 730 million yuan through a private placement to specific investors, with funds allocated for various precision manufacturing projects [17] - Fengli Intelligent was established in April 1995, focusing on the research, production, and sales of small modulus gears and precision reducers [17] Group 12 - Tuo Jing Technology's employee stockholding platforms plan to transfer 6.99 million shares, accounting for 2.50% of the total share capital [21] - Tuo Jing Technology was established in April 2010, focusing on the research, production, and sales of high-end semiconductor thin film equipment [21] Group 13 - Tuo Jing Life plans to acquire 72.86% of Wuhan Kanglu Biological Technology Co. for 291 million yuan, with plans for further acquisitions in 2026 and 2027 [22] - Tuo Jing Life was established in November 2003, focusing on the research, production, and sales of in vitro diagnostic products [22]

据统计，8月4日，盘后包括达意隆、山外山、开普检测、吉宏股份、红旗连锁、通达股份、神火股份、 康泰医学、步科股份、飞鹿股份、能辉科技、晶雪节能、胜宏科技、赛腾股份、雪迪龙、中芯国际、工 大高科、成都先导、飞乐音响、华电辽能、三维股份、奥锐特在内的22家A股上市公司披露减持情况。 当日暂无A股上市公司披露增持情况。 | 1 | 达意障 | 董事兼高级管理人员吴小满计划减持不超过4.22万股股份 | | --- | --- | --- | | 2 | 山外山 | 大健康和力远健鲲合计减持2.26%公司股份 | | 3 | 开普检测 | 副总经理贺春、张冉拟减持不超过0.54%公司股份 | | 4 | 吉宏股份 | 毒事长干亚朋计划减持不超过304万股 | | 5 | 红旗连锁 | 永辉超市拟减持不超过1%股份 | | 6 | 通达股份 | 控股股东拟减持不超过3%公司股份 | | 1 | 神火股份 | 普天工贸拟减持0.90%公司股份 | | 8 | 康泰医学 | 持股5%以上股东及部分董事、高管拟减持不超过3.59%股份 | | 9 | 步科股份 | 控股股东上海步进计划减持不超过3%公司股份 | | 10 | ...

Core Viewpoint - The company 康泰医学 (300869.SZ) announced that major shareholders plan to reduce their holdings, which may impact the stock's performance and investor sentiment [1] Shareholder Reduction Plan - Major shareholders, including Wang Guili and several board members and senior management, intend to collectively reduce their holdings by 14.416 million shares, representing 3.59% of the company's total share capital [1]

Group 1 - The company, Kangtai Medical (300869.SZ), announced that major shareholders, including Wang Guili and several board members, plan to reduce their holdings by a total of 14.416 million shares, which represents 3.59% of the company's total share capital [1]

每经AI快讯，康泰医学（SZ 300869，收盘价：20.54元）8月4日晚间发布公告称，康泰医学系统（秦皇 岛）股份有限公司持股5%以上股东王桂丽持有公司股份约4713万股（占公司总股本的11.73%），计划 在本公告披露之日起十五个交易日后的三个月内以集中竞价交易方式减持公司股份不超过400万股（占 公司总股本的1%），以大宗交易方式减持公司股份不超过800万股（占公司总股本的1.99%）。公司董 事兼高级管理人员杨志山、董事高瑞斌分别持有公司股份约216万股（占公司总股本的0.54%）、约123 万股（占公司总股本的0.31%），计划在本公告披露之日起十五个交易日后的三个月内以集中竞价交易 方式减持公司股份分别不超过约54万股（占公司总股本的0.13%）、30万股（占公司总股本的 0.07%）。公司高级管理人员付春元、寇国治、许云龙、刘振红、郑敏分别持有公司股份约248万股 （占公司总股本的0.62%）、约185万股（占公司总股本的0.46%）、约89万股（占公司总股本的 0.22%）、约63万股（占公司总股本的0.16%）、约50万股（占公司总股本的0.12%），计划在本公告披 露之日起十五个交易日后 ...

公司高级管理人员付春元、寇国治、许云龙、刘振红、郑敏分别持有公司股份2,476,772股(占公司总股 本的0.62%)、1,846,977股(占公司总股本的0.46%)、891,452股(占公司总股本的0.22%)、634,276股(占公 司总股本的0.16%)、495,876股(占公司总股本的0.12%)，计划在公告披露之日起十五个交易日后的三个 月内以集中竞价交易方式减持公司股份分别不超过619,000股(占公司总股本的0.15%)、460,000股(占公 司总股本的0.11%)、220,000股(占公司总股本的0.05%)、158,000股(占公司总股本的0.04%)、120,000股 (占公司总股本的0.03%)。 上述股东采取集中竞价交易方式减持的，在任意连续90个自然日内减持股份总数不超过公司股份总数的 1%。通过大宗交易方式进行减持的，在任意连续90个自然日内减持股份总数不超过公司股份总数的 2%。 格隆汇8月4日丨康泰医学(300869.SZ)公布，公司持股5%以上股东王桂丽持有公司股份47,126,226股(占 公司总股本的11.73%)，计划在公告披露之日起十五个交易日后的三个月内以集中竞 ...

人民财讯8月4日电，康泰医学（300869）8月4日晚间公告，股东王桂丽，公司董事兼高级管理人员杨志 山，董事高瑞斌，高级管理人员付春元、寇国治、许云龙、刘振红、郑敏拟合计减持不超3.59%公司股 份。 ...

公司董事兼高级管理人员杨志山、董事高瑞斌分别持有公司股份2,157,138股(占公司总股本的0.54%)、 1,230,902股(占公司总股本的0.31%)，计划在公告披露之日起十五个交易日后的三个月内以集中竞价交 易方式减持公司股份分别不超过539,000股(占公司总股本的0.13%)、300,000股(占公司总股本的0.07%)。 格隆汇8月4日丨康泰医学(300869.SZ)公布，公司持股5%以上股东王桂丽持有公司股份47,126,226股(占 公司总股本的11.73%)，计划在公告披露之日起十五个交易日后的三个月内以集中竞价交易方式减持公 司股份不超过4,000,000股(占公司总股本的1.00%)，以大宗交易方式减持公司股份不超过8,000,000股(占 公司总股本的1.99%)。 公司高级管理人员付春元、寇国治、许云龙、刘振红、郑敏分别持有公司股份2,476,772股(占公司总股 本的0.62%)、1,846,977股(占公司总股本的0.46%)、891,452股(占公司总股本的0.22%)、634,276股(占公 司总股本的0.16%)、495,876股(占公司总股本的0.12%)，计划在公告披 ...

Core Viewpoint - The major shareholders of Kangtai Medical (300869) plan to reduce their holdings, indicating potential changes in the company's ownership structure and investor sentiment [1] Shareholder Reduction Plans - Major shareholder Wang Guili intends to reduce holdings by up to 2.99% of the company's shares [1] - Other board members and senior management, including Yang Zhishan, Gao Ruibin, Fu Chunyu, Kou Guozhi, Xu Yunlong, Liu Zhenhong, and Zheng Min, plan to reduce their holdings by up to 0.13%, 0.07%, 0.15%, 0.11%, 0.05%, 0.04%, and 0.03% respectively [1] - The reduction period is set for three months starting fifteen trading days after the announcement [1]

康泰医学系统（秦皇岛）股份有限公司 关于持股 5%以上股东、部分董事及高级管理人员减持股份预披露公告 持股 5%以上股东王桂丽，董事兼高级管理人员杨志山，董事高瑞斌，高级管 理人员付春元、寇国治、许云龙、刘振红、郑敏保证向本公司提供的信息内容真实、 准确和完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证本公告内容与信息披露义务人提供的信息一致。 特别提示： 1、康泰医学系统（秦皇岛）股份有限公司（以下简称"公司"或"本公司"） 持股 5%以上股东王桂丽持有公司股份 47,126,226 股（占本公司总股本的 11.73%）， 计划在本公告披露之日起十五个交易日后的三个月内以集中竞价交易方式减持本 公司股份不超过 4,000,000 股（占本公司总股本的 1.00%），以大宗交易方式减持 本公司股份不超过 8,000,000 股（占本公司总股本的 1.99%）。 2、公司董事兼高级管理人员杨志山、董事高瑞斌分别持有公司股份 2,157,138 股（占本公司总股本的 0.54%）、1,230,902 股（占本公司总股本的 0.31%），计 划在本公告披露之日起十五个交易日后的三个月内以集中竞 ...